COVID-19 humoral response

COVID-19 humoral response

This article reviews studies on SARS-CoV-2 antibodies, including neutralizing antibodies (NAbs) and post-vaccination response. The SARS-CoV-2 virus is closely related to SARS-CoV and MERS-CoV, sharing 79% and 50% of its genome sequence with them, respectively. Antibodies are crucial in identifying a...

Full description

Bibliographic Details
Main Authors:	Adam Tworek, Andrzej Rydzewski, Grażyna Rydzewska, Martyna Głuszek-Osuch, Konrad Lewandowski
Format:	Article
Language:	English
Published:	Termedia Publishing House 2023-09-01
Series:	Studia Medyczne
Subjects:	sars-cov-2 neutralizing antibodies immune response covid-19 therapy cytokine storm.
Online Access:	https://www.termedia.pl/COVID-19-humoral-response,67,51536,1,1.html

Similar Items

Enzyme-Linked Immunosorbent Assay: An Adaptable Methodology to Study SARS-CoV-2 Humoral and Cellular Immune Responses
by: Amanda Izeli Portilho, et al.
Published: (2022-03-01)

Immune responses in mildly versus critically ill COVID-19 patients
by: Hamid Nasrollahi, et al.
Published: (2023-01-01)

Long-term analysis of humoral responses and spike-specific T cell memory to Omicron variants after different COVID-19 vaccine regimens
by: Chia-Lo Ho, et al.
Published: (2024-03-01)

Natural infection versus hybrid (natural and vaccination) humoral immune response to SARS-CoV-2: a comparative paired analysis
by: Laila AbdelWareth, et al.
Published: (2023-09-01)

Humoral Responses Elicited by SARS-CoV-2 mRNA Vaccine in People Living with HIV
by: Lorie Marchitto, et al.
Published: (2023-09-01)

Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults
by: Ricards Marcinkevics, et al.
Published: (2023-05-01)

Humoral Response to BNT162b2 Vaccine Against SARS-CoV-2 Variants Decays After Six Months
by: Tulio J. Lopera, et al.
Published: (2022-05-01)

Robust memory humoral immune response to SARS-CoV-2 in the tonsils of adults and children
by: Tarfa A. Altorki, et al.
Published: (2023-12-01)

Fundamental and Advanced Therapies, Vaccine Development against SARS-CoV-2
by: Nikola Hudakova, et al.
Published: (2021-05-01)

Immune Signature of COVID-19: In-Depth Reasons and Consequences of the Cytokine Storm
by: Paulina Niedźwiedzka-Rystwej, et al.
Published: (2022-04-01)

Early Humoral Response Correlates with Disease Severity and Outcomes in COVID-19 Patients
by: Anwar M. Hashem, et al.
Published: (2020-12-01)

Fading SARS-CoV-2 humoral VOC cross-reactivity and sustained cellular immunity in convalescent children and adolescents
by: Krystallenia Paniskaki, et al.
Published: (2023-11-01)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
by: Krystallenia Paniskaki, et al.
Published: (2022-10-01)

SARS-CoV-2: Some Aspects of Molecular Evolution, Cellular Pathogenesis, and Immune System Mechanism Elusion
by: Angela Quirino, et al.
Published: (2021-12-01)

Clinical Profile of SARS-CoV-2 Infection: Mechanisms of the Cellular Immune Response and Immunogenetic Markers in Patients from Brazil
by: Vanessa Pacheco, et al.
Published: (2023-07-01)

BNT162b2 mRNA SARS-CoV-2 Vaccine Elicits High Avidity and Neutralizing Antibodies in Healthcare Workers
by: Federico Pratesi, et al.
Published: (2021-06-01)

High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020
by: Shuting Zhang, et al.
Published: (2023-04-01)

Viral and Immunological Analytes are Poor Predictors of the Clinical Treatment Response in Kaposi’s Sarcoma Patients
by: Salum J. Lidenge, et al.
Published: (2020-06-01)

Hyperinflammatory Response in COVID-19: A Systematic Review
by: Marcos Jessé Abrahão Silva, et al.
Published: (2023-02-01)

Letter to the Editor Regarding "Evaluation of SARS-CoV-2 Specific Antibodies in Recovered Patients by Different ELISA Kits"
by: Nitin Deshpande
Published: (2023-12-01)

The persistence of SARS-CoV-2 neutralizing antibodies after COVID-19: A one-year observation. Is a SARS-CoV-2 vaccination booster dose necessary?
by: Adam Tworek, et al.
Published: (2023-03-01)

COVID-19: Immunopathogenesis
by: Deniz MAVİ, et al.
Published: (2020-06-01)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
by: Jenni Virtanen, et al.
Published: (2021-05-01)

An Evaluation of a SARS-CoV-2 Pseudovirus Neutralization Test and A Comparison to a SARS-CoV-2 Surrogate Virus Neutralization Test in a COVID-19 Long-Term Follow-Up Cohort
by: Constant Gillot, et al.
Published: (2024-03-01)

How Do Inflammatory Mediators, Immune Response and Air Pollution Contribute to COVID-19 Disease Severity? A Lesson to Learn
by: Cinzia Signorini, et al.
Published: (2021-02-01)

Longitudinal humoral and cell-mediated immune responses in a population-based cohort in Zurich, Switzerland between March and June 2022 - evidence for protection against Omicron SARS-CoV-2 infection by neutralizing antibodies and spike-specific T-cell responses
by: Kyra Denise Zens, et al.
Published: (2023-08-01)

Host-Based Treatments for Severe COVID-19
by: Lucrezia Mondini, et al.
Published: (2023-04-01)

Targeting Specific Checkpoints in the Management of SARS-CoV-2 Induced Cytokine Storm
by: Abdullahi Rabiu Abubakar, et al.
Published: (2022-03-01)

Systemic innate and adaptive immune responses to SARS-CoV-2 as it relates to other coronaviruses
by: Patrick O’Connell, et al.
Published: (2020-12-01)

Durability of Humoral and Cellular Immunity after an Extended Primary Series with Heterologous Inactivated SARS-CoV-2 Prime-Boost and ChAdOx1 nCoV-19 in Dialysis Patients (ICON3)
by: Sarinya Boongird, et al.
Published: (2022-07-01)

SARS-CoV-2-Neutralizing Humoral IgA Response Occurs Earlier but Is Modest and Diminishes Faster than IgG Response
by: Yuki Takamatsu, et al.
Published: (2022-12-01)

Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
by: Andrea Lombardi, et al.
Published: (2022-12-01)

Acquisition of Humoral Immune Responses in Convalescent Japanese People with SARS-CoV-2 (COVID-19) Infection in 2021
by: Koshiro Monzen, et al.
Published: (2023-08-01)

Retention of Neutralizing Response against SARS-CoV-2 Omicron Variant in Sputnik V-Vaccinated Individuals
by: Daniele Lapa, et al.
Published: (2022-05-01)

Adjunct Immunotherapies for the Management of Severely Ill COVID-19 Patients
by: Srinivasa Reddy Bonam, et al.
Published: (2020-05-01)

Development of SARS-CoV-2 vaccines: challenges, risks, and the way forward
by: Vipin M. Vashishtha, et al.
Published: (2021-06-01)

Persistent humoral and CD4+ TH cell immunity after mild SARS-COV-2 infection—The CoNAN long-term study
by: Clara Schnizer, et al.
Published: (2023-01-01)

Low humoral and cellular immune responses early after breakthrough infection may contribute to severe COVID-19
by: Chan Mi Lee, et al.
Published: (2023-03-01)

Post-Gam-COVID-Vac combined vector vaccine cellular and humoral immune response
by: Evgeniya V. Inviyaeva, et al.
Published: (2022-12-01)

Boosting with Multiple Doses of mRNA Vaccine after Priming with Two Doses of Protein Subunit Vaccine MVC-COV1901 Elicited Robust Humoral and Cellular Immune Responses against Emerging SARS-CoV-2 Variants
by: Chun-Hsiang Chiu, et al.
Published: (2022-10-01)